Ann Marie Navar at LBS 3 briefing

Ann Marie Navar, M.D., Ph.D., FAHA, an associate professor of cardiology at the University of Texas Southwestern Medical Center in Dallas. Presents findings in CORALreef Lipids – Efficacy and Safety of Enlicitide, an Oral PCSK9 Inhibitor, for Lowering LDL Cholesterol in Adults with or At-Risk for ASCVD: The Phase 3 CORALreef Lipids Trial (PL.ME.02).

Please see AHA/ASA Multimedia Materials Usage Policy.

I have read the AHA/ASA Multimedia Materials Usage Policy and agree to the terms of use

Download (433.6 kB)

This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.

CLOSE PROCEED